Similar articles

• Financial conflicts of interest in human subjects research: proposals for a more effective regulatory scheme.

  Jordan KA. Jordan KA. Wash Lee Law Rev. 2003 Winter;60(1):15-109. Wash Lee Law Rev. 2003. PMID: 16273696 No abstract available.
• Making clinical trials safer for human subjects.

  Baram M. Baram M. Am J Law Med. 2001;27(2-3):253-82. Am J Law Med. 2001. PMID: 11467112 No abstract available.
• Protecting research subjects--the crisis at Johns Hopkins.

  Steinbrook R. Steinbrook R. N Engl J Med. 2002 Feb 28;346(9):716-20. doi: 10.1056/NEJM200202283460924. N Engl J Med. 2002. PMID: 11870258 No abstract available.
• When do the federal regulations allow placebo-controlled trials in children?

  Miller FG, Wendler D, Wilfond B. Miller FG, et al. J Pediatr. 2003 Feb;142(2):102-7. doi: 10.1067/mpd.2003.43. J Pediatr. 2003. PMID: 12584527 Review. No abstract available.
• The standard of disclosure in human subject experimentation.

  Morin K. Morin K. J Leg Med. 1998 Jun;19(2):157-221. doi: 10.1080/01947649809511059. J Leg Med. 1998. PMID: 9658739 Review. No abstract available.